SCHEMBL23577993

SCHEMBL23577993

O=S(=O)(c1ccc(Br)cc1)N1CCC(c2ccc(C(F)(F)F)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
USP5 P45974 4/20 0.58
TP53 P04637 2/20 0.58
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
LMNA P02545 1/20 0.52
HTT P42858 1/20 0.52
GAA P10253 1/20 0.52
KDM4E B2RXH2 1/20 0.52
TSHR P16473 1/20 0.52
ALDH1A1 P00352 1/20 0.51
CNR1 P21554 3/20 0.50
HDAC6 Q9UBN7 1/20 0.50
EPHX2 P34913 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
TRPV4 Q9HBA0 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20772175 0.87 TP53 (0.77) TP53MEN1KMT2ALMNAHTT
SCHEMBL30044815 0.86 TP53 (0.57) USP5TP53MEN1KMT2ALMNA
SCHEMBL20772311 0.85 TP53 (0.79) USP5TP53MEN1KMT2ALMNA
SCHEMBL20772177 0.82 TP53 (0.75) USP5TP53MEN1KMT2ALMNA
SCHEMBL29716504 0.81 SMN1; SMN2 (0.61) TP53MEN1KMT2ALMNAHTT
SCHEMBL29264663 0.81 GAA (0.58) MEN1KMT2ALMNAGAAALDH1A1
SCHEMBL23577489 0.79 TP53 (0.50) USP5TP53MEN1KMT2ALMNA
SCHEMBL4161092 0.79 HTR2C (0.51) TP53MEN1KMT2ALMNAHTT
SCHEMBL28818511 0.78 HSD11B1 (0.60) MEN1KMT2ALMNAHTTGAA
SCHEMBL22688634 0.77 HTR2C (0.50) TP53MEN1KMT2ALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081509-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA Zydus Lifesciences Limited (IN) 2022-11-02 EP disclosed
CN-114901640-A Novel compounds useful for the treatment of dyslipidemia 兹杜斯生命科学有限公司 2022-08-12 CN disclosed
WO-2021130723-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA CADILA HEALTHCARE LIMITED (IN) 2021-07-01 WO disclosed